SNOA
Sonoma Pharmaceuticals, Inc.
$1.21
+0.00 (+0.00%)
At close · Jul 2
Market Cap
$5.79M
Shares
4,785,801
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.21
Open$1.22
Day$1.19–1.23
52W$0.97–6.92
Avg vol 30d167K
Short int5K · 0.1% float · 1.0d
Short vol10%
DataJan 2020–Jul 2026
Filing10-K · Jun 16
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Neutral
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−56% below
+
Price vs 50-day avg
+4% above
◦
RSI (14)
53 · neutral
+
MACD trend
positive
−
52-week position
4% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $1 › 200d $3 — 200d above 50d
+
Institutional flow
+6% holders QoQ · +4 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.09% of float · ▼ -90.0% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
17 holders — mid 2-yr range
Fundamentals
Strong
+
Revenue growth
+37% Y/Y
◦
Gross margin
38%, contracting
+
EPS growth
+32% Y/Y
−
Free cash flow
$-4.1M
+
Balance sheet
net cash $2.1M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
filed Jun 16, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−56% below
Bearish
Price vs 50-day avg
+4% above
Bullish
RSI (14)
53 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
4% · near low
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+6% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.09% of float · ▼ -90.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — mid 2-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 4%
52-wk high $7
vs 200-day avg -56%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SNOA
this stock
Sonoma Pharmaceuticals, Inc.
|
$5.79M | -66.8% | +36.7% | — | 0.1% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.99B | +7.6% | — | — | 0.3% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.25B | -2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SNOA | +6.1% | +0.0% | -68.0% | -1.6% | -66.8% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +4.7% | +1.3% | -76.0% | -1.4% | -76.0% |